Editorial [Hot Topic:Resent and Future Therapies for the Hepatocellular Carcinoma (Executive Editor: G. Giannelli)]
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3264-3264
Author(s):
G. Giannelli
The Development of Targeted Therapies for Hepatocellular Cancer
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3292-3300
Author(s):
D. Chattopadhyay, D. M. Manas and H. L. Reeves
Liver Transplantation for Hepatocellular Carcinoma: Current Role and Future Opportunities
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3265-3273
Author(s):
Felicitas L. Koller, Sunil K. Geevarghese and D. Lee Gorden
Tyrosine Kinase Inhibitors: A Potential Approach to the Treatment of Hepatocellular Carcinoma
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3301-3304
Author(s):
G. Giannelli, N. Napoli and S. Antonaci
Molecular Pathways and Related Target Therapies in Liver Carcinoma
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3279-3287
Author(s):
S. Tommasi, R. Pinto, B. Pilato and A. Paradiso
Cyclooxygenase-2 (COX-2) - A Therapeutic Target in Liver Cancer?
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3305-3315
Author(s):
Marco Breinig, Peter Schirmacher and Michael Andre Kern
Rationale for New Drugs Targeting the Tissue Microenvironment in Patients with HCC
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3288-3291
Author(s):
S. Antonaci and G. Giannelli
Cancer Control by Phytochemicals
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3394-3399
Author(s):
Hoyoku Nishino, Yoshiko Satomi, Harukuni Tokuda and Mitsuharu Masuda
Ethanol and Inflammation
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
6
Page:
264-270
Author(s):
Joanna Goral
Nongenomic Actions of Retinoids: Role of Nur77 and RXR in the Regulation of Apoptosis and Inflammation
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
6
Page:
315-331
Author(s):
Jin-Zhang Zeng and Xiao-kun Zhang